Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 22 |
GO:0042995 | cell projection | 2 | 22 |
GO:0043226 | organelle | 2 | 22 |
GO:0043227 | membrane-bounded organelle | 3 | 22 |
GO:0110165 | cellular anatomical entity | 1 | 22 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 22 |
GO:0005634 | nucleus | 5 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0005643 | nuclear pore | 3 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I2W0
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 4 |
GO:0015931 | nucleobase-containing compound transport | 5 | 4 |
GO:0050657 | nucleic acid transport | 6 | 4 |
GO:0050658 | RNA transport | 4 | 4 |
GO:0051028 | mRNA transport | 5 | 4 |
GO:0051179 | localization | 1 | 4 |
GO:0051234 | establishment of localization | 2 | 4 |
GO:0051236 | establishment of RNA localization | 3 | 4 |
GO:0071702 | organic substance transport | 4 | 4 |
GO:0071705 | nitrogen compound transport | 4 | 4 |
GO:0006405 | RNA export from nucleus | 5 | 2 |
GO:0006406 | mRNA export from nucleus | 6 | 2 |
GO:0006913 | nucleocytoplasmic transport | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 7 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0051168 | nuclear export | 6 | 2 |
GO:0051169 | nuclear transport | 4 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 11 |
GO:0043167 | ion binding | 2 | 10 |
GO:0043169 | cation binding | 3 | 10 |
GO:0046872 | metal ion binding | 4 | 10 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 483 | 485 | PF00675 | 0.451 |
CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.546 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.431 |
CLV_PCSK_KEX2_1 | 482 | 484 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 533 | 535 | PF00082 | 0.543 |
CLV_PCSK_PC1ET2_1 | 118 | 120 | PF00082 | 0.546 |
CLV_PCSK_PC1ET2_1 | 192 | 194 | PF00082 | 0.471 |
CLV_PCSK_PC1ET2_1 | 533 | 535 | PF00082 | 0.409 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.417 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.373 |
CLV_PCSK_SKI1_1 | 234 | 238 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 430 | 434 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 533 | 537 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.411 |
CLV_Separin_Metazoa | 133 | 137 | PF03568 | 0.476 |
DOC_CYCLIN_RxL_1 | 138 | 152 | PF00134 | 0.481 |
DOC_CYCLIN_RxL_1 | 154 | 161 | PF00134 | 0.479 |
DOC_CYCLIN_RxL_1 | 77 | 84 | PF00134 | 0.510 |
DOC_CYCLIN_yClb1_LxF_4 | 182 | 188 | PF00134 | 0.472 |
DOC_CYCLIN_yCln2_LP_2 | 403 | 409 | PF00134 | 0.391 |
DOC_MAPK_DCC_7 | 216 | 226 | PF00069 | 0.547 |
DOC_MAPK_gen_1 | 136 | 145 | PF00069 | 0.415 |
DOC_MAPK_MEF2A_6 | 219 | 226 | PF00069 | 0.444 |
DOC_MAPK_MEF2A_6 | 364 | 372 | PF00069 | 0.508 |
DOC_MAPK_MEF2A_6 | 508 | 516 | PF00069 | 0.546 |
DOC_MAPK_MEF2A_6 | 80 | 87 | PF00069 | 0.490 |
DOC_MAPK_NFAT4_5 | 80 | 88 | PF00069 | 0.494 |
DOC_PP2B_LxvP_1 | 237 | 240 | PF13499 | 0.532 |
DOC_PP2B_LxvP_1 | 515 | 518 | PF13499 | 0.533 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.466 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.534 |
DOC_USP7_MATH_1 | 320 | 324 | PF00917 | 0.572 |
DOC_USP7_MATH_1 | 335 | 339 | PF00917 | 0.501 |
DOC_USP7_MATH_1 | 500 | 504 | PF00917 | 0.508 |
DOC_USP7_MATH_1 | 524 | 528 | PF00917 | 0.533 |
DOC_USP7_MATH_2 | 349 | 355 | PF00917 | 0.377 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.493 |
DOC_WW_Pin1_4 | 461 | 466 | PF00397 | 0.515 |
DOC_WW_Pin1_4 | 471 | 476 | PF00397 | 0.540 |
LIG_14-3-3_CanoR_1 | 326 | 334 | PF00244 | 0.478 |
LIG_14-3-3_CanoR_1 | 430 | 435 | PF00244 | 0.344 |
LIG_Actin_WH2_2 | 311 | 328 | PF00022 | 0.442 |
LIG_APCC_ABBAyCdc20_2 | 456 | 462 | PF00400 | 0.620 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.548 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.374 |
LIG_BRCT_BRCA1_1 | 327 | 331 | PF00533 | 0.413 |
LIG_BRCT_BRCA1_1 | 424 | 428 | PF00533 | 0.404 |
LIG_BRCT_BRCA1_1 | 466 | 470 | PF00533 | 0.547 |
LIG_BRCT_BRCA1_1 | 83 | 87 | PF00533 | 0.451 |
LIG_BRCT_BRCA1_1 | 91 | 95 | PF00533 | 0.446 |
LIG_BRCT_BRCA1_2 | 123 | 129 | PF00533 | 0.390 |
LIG_BRCT_BRCA1_2 | 83 | 89 | PF00533 | 0.493 |
LIG_FHA_1 | 305 | 311 | PF00498 | 0.461 |
LIG_FHA_1 | 429 | 435 | PF00498 | 0.314 |
LIG_FHA_1 | 488 | 494 | PF00498 | 0.448 |
LIG_FHA_2 | 424 | 430 | PF00498 | 0.432 |
LIG_FHA_2 | 499 | 505 | PF00498 | 0.502 |
LIG_IRF3_LxIS_1 | 283 | 289 | PF10401 | 0.489 |
LIG_LIR_Gen_1 | 121 | 130 | PF02991 | 0.390 |
LIG_LIR_Gen_1 | 262 | 272 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 281 | 288 | PF02991 | 0.523 |
LIG_LIR_Gen_1 | 88 | 98 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 121 | 125 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 269 | 275 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 281 | 286 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 328 | 334 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 88 | 94 | PF02991 | 0.498 |
LIG_LRP6_Inhibitor_1 | 148 | 154 | PF00058 | 0.357 |
LIG_MLH1_MIPbox_1 | 424 | 428 | PF16413 | 0.444 |
LIG_MYND_1 | 111 | 115 | PF01753 | 0.449 |
LIG_NRBOX | 155 | 161 | PF00104 | 0.348 |
LIG_NRBOX | 196 | 202 | PF00104 | 0.377 |
LIG_NRBOX | 81 | 87 | PF00104 | 0.363 |
LIG_PCNA_PIPBox_1 | 252 | 261 | PF02747 | 0.474 |
LIG_PDZ_Class_2 | 533 | 538 | PF00595 | 0.317 |
LIG_Pex14_2 | 372 | 376 | PF04695 | 0.548 |
LIG_PTB_Apo_2 | 370 | 377 | PF02174 | 0.537 |
LIG_REV1ctd_RIR_1 | 425 | 434 | PF16727 | 0.379 |
LIG_SH2_CRK | 122 | 126 | PF00017 | 0.488 |
LIG_SH2_CRK | 194 | 198 | PF00017 | 0.474 |
LIG_SH2_CRK | 272 | 276 | PF00017 | 0.437 |
LIG_SH2_CRK | 91 | 95 | PF00017 | 0.492 |
LIG_SH2_NCK_1 | 122 | 126 | PF00017 | 0.488 |
LIG_SH2_NCK_1 | 272 | 276 | PF00017 | 0.344 |
LIG_SH2_NCK_1 | 91 | 95 | PF00017 | 0.474 |
LIG_SH2_SRC | 277 | 280 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 213 | 217 | PF00017 | 0.391 |
LIG_SH2_STAP1 | 91 | 95 | PF00017 | 0.515 |
LIG_SH2_STAT3 | 258 | 261 | PF00017 | 0.505 |
LIG_SH2_STAT3 | 279 | 282 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 258 | 261 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 277 | 280 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 402 | 405 | PF00017 | 0.518 |
LIG_SH3_3 | 403 | 409 | PF00018 | 0.391 |
LIG_SH3_3 | 411 | 417 | PF00018 | 0.563 |
LIG_SH3_3 | 462 | 468 | PF00018 | 0.615 |
LIG_SUMO_SIM_anti_2 | 199 | 204 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 429 | 435 | PF11976 | 0.448 |
LIG_TRAF2_1 | 503 | 506 | PF00917 | 0.419 |
LIG_TYR_ITIM | 120 | 125 | PF00017 | 0.486 |
LIG_UBA3_1 | 82 | 89 | PF00899 | 0.387 |
LIG_WRC_WIRS_1 | 424 | 429 | PF05994 | 0.482 |
MOD_CDK_SPxK_1 | 471 | 477 | PF00069 | 0.589 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.436 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.499 |
MOD_CK1_1 | 281 | 287 | PF00069 | 0.437 |
MOD_CK1_1 | 338 | 344 | PF00069 | 0.521 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.607 |
MOD_CK2_1 | 473 | 479 | PF00069 | 0.422 |
MOD_CK2_1 | 499 | 505 | PF00069 | 0.528 |
MOD_CK2_1 | 524 | 530 | PF00069 | 0.501 |
MOD_Cter_Amidation | 5 | 8 | PF01082 | 0.577 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.605 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.359 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.325 |
MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.594 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.419 |
MOD_GlcNHglycan | 301 | 304 | PF01048 | 0.394 |
MOD_GlcNHglycan | 337 | 340 | PF01048 | 0.573 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.750 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.624 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.649 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.538 |
MOD_GSK3_1 | 242 | 249 | PF00069 | 0.560 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.393 |
MOD_GSK3_1 | 320 | 327 | PF00069 | 0.502 |
MOD_GSK3_1 | 408 | 415 | PF00069 | 0.499 |
MOD_GSK3_1 | 428 | 435 | PF00069 | 0.366 |
MOD_GSK3_1 | 437 | 444 | PF00069 | 0.371 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.693 |
MOD_N-GLC_1 | 102 | 107 | PF02516 | 0.425 |
MOD_N-GLC_1 | 178 | 183 | PF02516 | 0.522 |
MOD_N-GLC_1 | 498 | 503 | PF02516 | 0.528 |
MOD_N-GLC_1 | 59 | 64 | PF02516 | 0.713 |
MOD_N-GLC_1 | 66 | 71 | PF02516 | 0.694 |
MOD_N-GLC_2 | 358 | 360 | PF02516 | 0.296 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.419 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.429 |
MOD_NEK2_1 | 278 | 283 | PF00069 | 0.442 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.382 |
MOD_NEK2_1 | 381 | 386 | PF00069 | 0.493 |
MOD_NEK2_1 | 423 | 428 | PF00069 | 0.353 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.380 |
MOD_NEK2_2 | 392 | 397 | PF00069 | 0.335 |
MOD_PIKK_1 | 246 | 252 | PF00454 | 0.482 |
MOD_PIKK_1 | 278 | 284 | PF00454 | 0.530 |
MOD_PIKK_1 | 325 | 331 | PF00454 | 0.525 |
MOD_PIKK_1 | 408 | 414 | PF00454 | 0.502 |
MOD_PIKK_1 | 89 | 95 | PF00454 | 0.492 |
MOD_PK_1 | 178 | 184 | PF00069 | 0.327 |
MOD_PKA_2 | 215 | 221 | PF00069 | 0.496 |
MOD_PKA_2 | 325 | 331 | PF00069 | 0.552 |
MOD_Plk_1 | 149 | 155 | PF00069 | 0.416 |
MOD_Plk_1 | 178 | 184 | PF00069 | 0.457 |
MOD_Plk_1 | 259 | 265 | PF00069 | 0.492 |
MOD_Plk_1 | 362 | 368 | PF00069 | 0.502 |
MOD_Plk_1 | 381 | 387 | PF00069 | 0.317 |
MOD_Plk_1 | 428 | 434 | PF00069 | 0.370 |
MOD_Plk_1 | 87 | 93 | PF00069 | 0.510 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.448 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.467 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.367 |
MOD_Plk_4 | 423 | 429 | PF00069 | 0.416 |
MOD_Plk_4 | 507 | 513 | PF00069 | 0.484 |
MOD_Plk_4 | 81 | 87 | PF00069 | 0.382 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.486 |
MOD_ProDKin_1 | 461 | 467 | PF00069 | 0.515 |
MOD_ProDKin_1 | 471 | 477 | PF00069 | 0.534 |
MOD_SUMO_rev_2 | 502 | 510 | PF00179 | 0.544 |
TRG_DiLeu_BaEn_1 | 97 | 102 | PF01217 | 0.557 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.403 |
TRG_ENDOCYTIC_2 | 272 | 275 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 91 | 94 | PF00928 | 0.519 |
TRG_ER_diArg_1 | 142 | 145 | PF00400 | 0.494 |
TRG_ER_diArg_1 | 481 | 484 | PF00400 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 129 | 133 | PF00026 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 144 | 149 | PF00026 | 0.451 |
TRG_Pf-PMV_PEXEL_1 | 332 | 337 | PF00026 | 0.498 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8E9 | Leptomonas seymouri | 24% | 86% |
A0A0N0P8S6 | Leptomonas seymouri | 74% | 100% |
A0A0S4IRU5 | Bodo saltans | 27% | 100% |
A0A0S4IW66 | Bodo saltans | 28% | 100% |
A0A1X0P4A3 | Trypanosomatidae | 45% | 100% |
A0A1X0P4L1 | Trypanosomatidae | 26% | 92% |
A0A3R7NID6 | Trypanosoma rangeli | 26% | 92% |
A0A3S7X0T0 | Leishmania donovani | 100% | 100% |
A0A3S7X0T8 | Leishmania donovani | 26% | 87% |
A4HFU3 | Leishmania braziliensis | 87% | 100% |
A4HFU4 | Leishmania braziliensis | 26% | 100% |
A4I2W1 | Leishmania infantum | 26% | 87% |
D0A641 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
D0A644 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9ADE7 | Leishmania major | 96% | 100% |
E9ADE8 | Leishmania major | 25% | 100% |
E9AZ71 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9AZ72 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
V5B0W6 | Trypanosoma cruzi | 26% | 93% |
V5BQG4 | Trypanosoma cruzi | 44% | 100% |